Top insider buys: Dec 25 – Dec 31, 2023

The largest open-market purchases company insiders reported on SEC Form 4 between Dec 25 – Dec 31, 2023.

Week 52, 2023

#	Company	Who bought	Shares	Value	Source
1	RNGE RANGE IMPACT, INC.	2 officers/directors Cluster buy Michael R. Cavanaugh, Edward F. Feighan	1,666,667	$250K	SEC filings
2	ECAT BlackRock ESG Capital Allocation Term Trust	10% Owner Saba Capital Management, L.P.	506,718	$8.3M	SEC filings
3	ELTX Elicio Therapeutics, Inc.	Director Yekaterina Chudnovsky	1,213,000	$7.0M	SEC filings
4	KALV KalVista Pharmaceuticals, Inc.	10% Owner Venrock Healthcare Capital Partners III, L.P.	519,017	$6.5M	SEC filings
5	VRCA Verrica Pharmaceuticals Inc.	10% Owner PERCEPTIVE ADVISORS LLC	826,268	$5.6M	SEC filings
6	HPK HighPeak Energy, Inc.	Chief Executive Officer Jack Hightower	314,472	$4.6M	SEC filings
7	SYRS Syros Pharmaceuticals, Inc.	Director Srinivas Akkaraju	904,977	$4.0M	SEC filings
8	IHT INNSUITES HOSPITALITY TRUST	President & CEO James F. Wirth	1,500	$3.4M	SEC filings
9	UFI UNIFI INC	Director Kenneth G. Langone	500,000	$2.9M	SEC filings
10	MOBX Chavant Capital Acquisition Corp.	10% Owner Chavant Capital Partners LLC	199,737	$2.0M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.